GAMMA-LINOLENIC ACID FOR ATTENTION-DEFICIT HYPERACTIVITY DISORDER - PLACEBO-CONTROLLED COMPARISON TO D-AMPHETAMINE

被引：77
|
作者：
ARNOLD, LE [1 ]
KLEYKAMP, D [1 ]
VOTOLATO, NA [1 ]
TAYLOR, WA [1 ]
KONTRAS, SB [1 ]
TOBIN, K [1 ]
机构：
[1] WRIGHT STATE UNIV,DAYTON,OH 45435
来源：
BIOLOGICAL PSYCHIATRY | 1989年 / 25卷 / 02期
关键词：
D O I：
10.1016/0006-3223(89)90167-4
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：222 / 228
页数：7
相关论文
共 50 条
  • [31] Evaluation of Patients' and Parents' Quality of Life in a Randomized Placebo-Controlled Atomoxetine Study in Attention-Deficit/Hyperactivity Disorder
    Escobar, Rodrigo
    Montoya, Alonso
    Polavieja, Pepa
    Cardo, Esther
    Artigas, Josep
    Hervas, Amaia
    Fuentes, Joaquin
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2009, 19 (03) : 253 - 263
  • [32] Randomized, Placebo-Controlled, Crossover Study of Methylphenidate for Attention-Deficit/Hyperactivity Disorder Symptoms in Preschoolers with Developmental Disorders
    Ghuman, Jaswinder K.
    Aman, Michael G.
    Lecavalier, Luc
    Riddle, Mark A.
    Gelenberg, Alan
    Wright, Ron
    Rice, Sydney
    Ghuman, Harinder S.
    Fort, Carolyn
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2009, 19 (04) : 329 - 339
  • [33] Ginkgo biloba in the treatment of attention-deficit/hyperactivity disorder in children and adolescents. A randomized, placebo-controlled, trial
    Shakibaei, Fereshteh
    Radmanesh, Mehrsa
    Salari, Elham
    Mahaki, Behzad
    COMPLEMENTARY THERAPIES IN CLINICAL PRACTICE, 2015, 21 (02) : 61 - 67
  • [34] EFFICACY AND SAFETY OF SHP465 MIXED AMPHETAMINE SALTS IN CHILDREN AND ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD): A RANDOMIZED, PLACEBO-CONTROLLED STUDY
    Brams, Matthew
    Childress, Ann
    Greenbaum, Michael S.
    Yu, Ming
    Yan, Brian
    Jaffee, Margo
    Robertson, Brigitte
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2017, 56 (10): : S165 - S165
  • [35] Serum Ferritin and Amphetamine Response in Youth with Attention-Deficit/Hyperactivity Disorder
    Calarge, Chadi
    Farmer, Cristan
    DiSilvestro, Robert
    Arnold, L. Eugene
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2010, 20 (06) : 495 - 502
  • [36] Pharmacology of methylphenidate, amphetamine enantiomers and pemoline in attention-deficit hyperactivity disorder
    Patrick, KS
    Markowitz, JS
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 1997, 12 (06) : 527 - 546
  • [37] Does zinc moderate essential fatty acid and amphetamine treatment of attention-deficit/hyperactivity disorder?
    Arnold, LE
    Pinkham, SM
    Votolato, N
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2000, 10 (02) : 111 - 117
  • [38] Vitamin mineral treatment of attention-deficit hyperactivity disorder in adults: double-blind randomised placebo-controlled trial
    Rucklidge, Julia J.
    Frampton, Chris M.
    Gorman, Brigette
    Boggis, Anna
    BRITISH JOURNAL OF PSYCHIATRY, 2014, 204 (04) : 306 - 315
  • [39] Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: A randomized, placebo-controlled, dose-response study
    Michelson, D
    Faries, D
    Wernicke, J
    Kelsey, D
    Kendrick, K
    Sallee, FR
    Spencer, T
    PEDIATRICS, 2001, 108 (05) : E83
  • [40] Dasotraline in Children with Attention-Deficit/Hyperactivity Disorder: A Six-Week, Placebo-Controlled, Fixed-Dose Trial
    Findling, Robert L.
    Adler, Lenard A.
    Spencer, Thomas J.
    Goldman, Robert
    Hopkins, Seth C.
    Koblan, Kenneth S.
    Kent, Justine
    Hsu, Jay
    Loebel, Antony
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2019, 29 (02) : 80 - 89
12345